Time-gated luminescence assay using nonmetal probes for determination of protein kinase activity-based disease markers

Analytical Biochemistry

Volumn 422, Issue 2, 2012, Pages 79-88

  Kasari, Marje ^a   Padrik, Peeter ^a,b   Vaasa, Angela ^a   Saar, Kristi ^b   Leppik, Krista ^b   Soplepmann, Jaan ^b   Uri, Asko ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b TARTU UNIVERSITY HOSPITAL   (Estonia)

Author keywords

Biomarker; ECPKA; Homogeneous biomarker test; PKA; Protein kinase analysis; Time gated luminescence

Indexed keywords

BIOMARKERS; ENZYMES; OPTICAL PROPERTIES; PATIENT TREATMENT; PROBES;

BIOLOGICAL SOLUTIONS; CATALYTIC SUBUNITS; DETERMINATION OF PROTEINS; ECPKA; ITS APPLICATIONS; LUMINESCENCE ASSAY; PROTEIN KINASE; PROTEIN KINASE A;

LUMINESCENCE;

CYCLIC AMP DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT; LANTHANIDE;

ARTICLE; BINDING AFFINITY; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); DISEASE MARKER; ENZYME ACTIVITY; HUMAN; LUMINESCENCE; MAJOR CLINICAL STUDY; MOLECULAR PROBE; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION;

EID: 84857917847     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2011.12.048     Document Type: Article

References (37)

1. P. Cohen Protein kinases: the major drug targets of the twenty-first century? Nat. Rev. Drug Discov. 1 2002 309 315 (Pubitemid 37361447)
2. S.J. Baker, and E.P. Reddy Targeted inhibition of kinases in cancer therapy Mt. Sinai J. Med. 77 2010 573 586
3. K. Parikh, and M.P. Peppelenbosch Kinome profiling of clinical cancer specimens Cancer Res. 70 2010 2575 2578
4. S.M. Hanash, C.S. Baik, and O. Kallioniemi Emerging molecular biomarkers - blood-based strategies to detect and monitor cancer Nat. Rev. Clin. Oncol. 8 2011 142 150
5. N.L. Anderson Libraries of specific assays covering whole proteomes: from yeast to man Clin. Chem. 56 2010 1521 1522
6. S. Schenk, G.J. Schoenhals, G. de Souza, and M. Mann A high confidence, manually validated human blood plasma protein reference set BMC Med. Genomics 1 2008 1 28
7. Y.S. Cho, Y.N. Lee, and Y.S. Cho-Chung Biochemical characterization of extracellular cAMP-dependent protein kinase as a tumor marker Biochem. Biophys. Res. Commun. 278 2000 679 684
8. M. Berna, and B. Ackermann Increased throughput for low-abundance protein biomarker verification by liquid chromatography/tandem mass spectrometry Anal. Chem. 81 2009 3950 3956
9. Y.S. Cho, Y.G. Park, Y.N. Lee, M.K. Kim, S. Bates, L. Tan, and Y.S. Cho-Chung Extracellular protein kinase A as a cancer biomarker: its expression by tumor cells and reversal by a myristate-lacking Calpha and RIIbeta subunit overexpression Proc. Natl. Acad. Sci. USA 97 2000 835 840 (Pubitemid 30070396)
10. M.E. Cvijic, T. Kita, W. Shih, R.S. DiPaola, and K.V. Chin Extracellular catalytic subunit activity of the cAMP-dependent protein kinase in prostate cancer Clin. Cancer Res. 6 2000 2309 2317 (Pubitemid 30399197)
11. T. Kita, J. Goydos, E. Reitman, R. Ravatn, Y. Lin, W.C. Shih, Y. Kikuchi, and K.V. Chin Extracellular cAMP-dependent protein kinase (ECPKA) in melanoma Cancer Lett. 208 2004 187 191 (Pubitemid 38624160)
12. H. Wang, M. Li, W. Lin, W. Wang, Z. Zhang, E.R. Rayburn, J. Lu, D. Chen, X. Yue, F. Shen, F. Jiang, J. He, W. Wei, X. Zeng, and R. Zhang Extracellular activity of cyclic AMP-dependent protein kinase as a biomarker for human cancer detection: distribution characteristics in a normal population and cancer patients Cancer Epidemiol. Biomarkers Prev. 16 2007 789 795 (Pubitemid 46650583)
13. A.K. Hagan, and T. Zuchner Lanthanide-based time-resolved luminescence immunoassays Anal. Bioanal. Chem. 400 2011 2847 2864
14. A. Uri, M. Lust, A. Vaasa, D. Lavogina, K. Viht, and E. Enkvist Bisubstrate fluorescent probes and biosensors in binding assays for HTS of protein kinase inhibitors Biochim. Biophys. Acta 2010 1804 541 546
15. A. Vaasa, I. Viil, E. Enkvist, K. Viht, G. Raidaru, D. Lavogina, and A. Uri High-affinity bisubstrate probe for fluorescence anisotropy binding/displacement assays with protein kinases PKA and ROCK Anal. Biochem. 385 2009 85 93
16. A. Vaasa, M. Lust, A. Terrin, A. Uri, and M. Zaccolo Small-molecule FRET probes for protein kinase activity monitoring in living cells Biochem. Biophys. Res. Commun. 397 2010 750 755
17. E. Enkvist, A. Vaasa, M. Kasari, M. Kriisa, T. Ivan, K. Ligi, G. Raidaru, and A. Uri Protein-induced long lifetime luminescence of nonmetal probes ACS Chem. Biol. 6 2011 1052 1062
18. G. Manning, D.B. Whyte, R. Martinez, T. Hunter, and S. Sudarsanam The protein kinase complement of the human genome Science 298 2002 1912 1934 (Pubitemid 35425239)
19. D. Lavogina, M. Lust, I. Viil, N. Konig, G. Raidaru, J. Rogozina, E. Enkvist, A. Uri, and D. Bossemeyer Structural analysis of ARC-type inhibitor (ARC-1034) binding to protein kinase A catalytic subunit and rational design of bisubstrate analogue inhibitors of basophilic protein kinases J. Med. Chem. 52 2009 308 321
20. K. Viht, A. Vaasa, G. Raidaru, E. Enkvist, and A. Uri Fluorometric TLC assay for evaluation of protein kinase inhibitors Anal. Biochem. 340 2005 165 170 (Pubitemid 40404112)
21. R. Connally, D. Jin, and J. Piper High intensity solid-state UV source for time-gated luminescence microscopy Cytometry A 69 2006 1020 1027 (Pubitemid 44521983)
22. R. Connally, D. Veal, and J. Piper Flash lamp-excited time-resolved fluorescence microscope suppresses autofluorescence in water concentrates to deliver an 11-fold increase in signal-to-noise ratio J. Biomed. Opt. 9 2004 725 734
23. C. Frelin, and D. Guedin Why are circulating concentrations of endothelin-1 so low? Cardiovasc. Res. 28 1994 1613 1622 (Pubitemid 24344133)
24. ICH, Q2(R1): Validation of Analytical Procedures: Text and Methodology, International Conference on Harmonisation, 2005.
25. J. Yuan, and G. Wang Lanthanide-based luminescence probes and time-resolved luminescence bioassays Trends Anal. Chem. 25 2006 490 500 (Pubitemid 44294446)
26. G.D. Dalton, and W.L. Dewey Protein kinase inhibitor peptide (PKI): a family of endogenous neuropeptides that modulate neuronal cAMP-dependent protein kinase function Neuropeptides 40 2006 23 34 (Pubitemid 43255410)
27. D.M. Gamm, and M.D. Uhler Isoform-specific differences in the potencies of murine protein kinase inhibitors are due to nonconserved amino-terminal residues J. Biol. Chem. 270 1995 7227 7232
28. K. Viht, S. Schweinsberg, M. Lust, A. Vaasa, G. Raidaru, D. Lavogina, A. Uri, and F.W. Herberg Surface-plasmon-resonance-based biosensor with immobilized bisubstrate analog inhibitor for the determination of affinities of ATP- and protein-competitive ligands of cAMP-dependent protein kinase Anal. Biochem. 362 2007 268 277 (Pubitemid 46227325)
29. G. Mathis Probing molecular interactions with homogeneous techniques based on rare earth cryptates and fluorescence energy transfer Clin. Chem. 41 1995 1391 1397
30. G. Mathis Rare earth cryptates and homogeneous fluoroimmunoassays with human sera Clin. Chem. 39 1993 1953 1959 (Pubitemid 23277039)
31. H. Bazin, M. Preaudat, E. Trinquet, and G. Mathis Homogeneous time resolved fluorescence resonance energy transfer using rare earth cryptates as a tool for probing molecular interactions in biology Spectrochim. Acta A Mol. Biomol. Spectrosc. 57 2001 2197 2211 (Pubitemid 32867022)
32. F. Degorce, A. Card, S. Soh, E. Trinquet, G.P. Knapik, and B. Xie HTRF: a technology tailored for drug discovery - a review of theoretical aspects and recent applications Curr. Chem. Genomics 3 2009 22 32
33. Cisbio, Application note 7; New europium cryptates to probe molecular interactions using HTRF; www.htrf.com/files/resources/htrf-an07.pdf, 2004.
34. M. Eigenthaler, C. Nolte, M. Halbrugge, and U. Walter Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells Eur. J. Biochem. 205 1992 471 481
35. R.A. Bowen, G.L. Hortin, G. Csako, O.H. Otanez, and A.T. Remaley Impact of blood collection devices on clinical chemistry assays Clin. Biochem. 43 2010 4 25
36. Y. Yuana, R.M. Bertina, and S. Osanto Pre-analytical and analytical issues in the analysis of blood microparticles Thromb. Haemost. 105 2011 396 408
37. D.H. Jackson, and R.E. Banks Banking of clinical samples for proteomic biomarker studies: a consideration of logistical issues with a focus on pre-analytical variation Proteomics Clin. Appl. 4 2010 250 270